These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9116097)

  • 1. Cause-specific mortality in women receiving hormone replacement therapy.
    Schairer C; Adami HO; Hoover R; Persson I
    Epidemiology; 1997 Jan; 8(1):59-65. PubMed ID: 9116097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.
    Persson I; Yuen J; Bergkvist L; Schairer C
    Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
    Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
    Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.
    Falkeborn M; Persson I; Terént A; Adami HO; Lithell H; Bergström R
    Arch Intern Med; 1993 May; 153(10):1201-9. PubMed ID: 8388207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different menopausal hormone regimens and risk of breast cancer.
    Brusselaers N; Tamimi RM; Konings P; Rosner B; Adami HO; Lagergren J
    Ann Oncol; 2018 Aug; 29(8):1771-1776. PubMed ID: 29917061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
    Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
    Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of endometrial cancer following estrogen replacement with and without progestins.
    Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
    J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement.
    Persson I; Weiderpass E; Bergkvist L; Bergström R; Schairer C
    Cancer Causes Control; 1999 Aug; 10(4):253-60. PubMed ID: 10482483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect.
    Yuen J; Persson I; Bergkvist L; Hoover R; Schairer C; Adami HO
    Cancer Causes Control; 1993 Jul; 4(4):369-74. PubMed ID: 8394149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy.
    Tannen RL; Weiner MG; Xie D; Barnhart K
    Hum Reprod; 2007 Jun; 22(6):1769-77. PubMed ID: 17347166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of estrogens and progestogens.
    L'Hermite M
    Maturitas; 1990 Sep; 12(3):215-46. PubMed ID: 2170823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
    McGonigle KF; Karlan BY; Barbuto DA; Leuchter RS; Lagasse LD; Judd HL
    Gynecol Oncol; 1994 Oct; 55(1):126-32. PubMed ID: 7959253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
    Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
    JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.